Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

US Patent 7517531 · Granted Apr 14, 2009

Assignee

Inventors

View full patent text on Google Patents →